New breakthrough Alzheimer's drug gets unanimous backing from FDA advisors - New York Post
nypost.comSubmitted by newyorkpost9062 in business
The vote clears the way for a final FDA decision on the treatment, which initially had been expected earlier this year before the agency called for the meeting so its independent panel of experts c…